日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model

TNFR1决定IKKγ/Nemo基因模型中慢性肝损伤的进展

Cubero, F J; Singh, A; Borkham-Kamphorst, E; Nevzorova, Y A; Al Masaoudi, M; Haas, U; Boekschoten, M V; Gassler, N; Weiskirchen, R; Muller, M; Liedtke, C; Trautwein, C

Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality

肝纤维化、纤维化发生和遗传易感性的生物标志物:介于虚构与现实之间

Gressner, O A; Weiskirchen, R; Gressner, A M

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

现代肝纤维化发病机制理论认为,肝星状细胞和TGF-β是主要参与者和治疗靶点。

Gressner, A M; Weiskirchen, R

LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1.

LIM结构域蛋白富含半胱氨酸和甘氨酸的蛋白2 (CRP2) 是肝星状细胞的新型标志物,也是活化STAT1蛋白抑制剂的结合伴侣

Weiskirchen R, Moser M, Weiskirchen S, Erdel M, Dahmen S, Buettner R, Gressner A M

Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts

大鼠肝星状细胞和大鼠肌成纤维细胞原代培养中基因递送装置的比较评价

Weiskirchen, R; Kneifel, J; Weiskirchen, S; van de Leur, E; Kunz, D; Gressner, A M

A novel function for Myc: inhibition of C/EBP-dependent gene activation

Myc 的一个新功能:抑制 C/EBP 依赖性基因激活

Mink, S; Mutschler, B; Weiskirchen, R; Bister, K; Klempnauer, K H